WHO ICTRP trial
Studying the effect of platelet-rich plasma (PRP) and intralipid therapies on…
IRCT20240515061807N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20240515061807N1 |
|---|---|
| Public title | Studying the effect of platelet-rich plasma (PRP) and intralipid therapies on pregnancy outcomes in patients with recurrent implantation failure |
| Scientific title | Studying the effect of platelet-rich plasma (PRP) and intralipid therapies on pregnancy outcomes in patients with recurrent implantation failure |
| Primary sponsor | Islamic Azad University |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Infertility. Female infertility |
| Interventions | Intervention 1: Intervention group: PRP is prepared from autologous blood using a two-step process. Approximately 8.5 mL of peripheral venous blood is drawn into a syringe containing 1.5 mL of anticoagulant acid citrate A (ACD-A) solution… |
| Registration date | Jan 28, 2025 |
| Target size | 240 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: